There are a number of benefits to it: Cost
(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
Because IV therapy involves venous access, infection-prevention standards matter every visit
Severe, persistent vomiting
For L6-GLUT4myc cells, differentiation was initiated at 8090% confluence using -MEM supplemented with 2% horse serum (HS), refreshed every 23 days
With a 10 mg/mL vial, a 15 mg dose requires drawing 150 units, which exceeds a 1 mL syringe